The new Bausch and Lomb Akreos MICS lens, already on the market in other countries, is now available for U.S. cataract patients. The lens can be inserted through a tiny, 1.8mm incision, for better wound sealability, reduction in below-the-surface cell loss and reduction in surgery-caused astigmatism, according to the company. The Centers for Medicare and Medicaid Services granted the New Technology Intraocular Lens designation to the lens for its design that reduces spherical aberration.

Ocutec Ltd, the has announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene) glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses. It is anticipated that the lenses will provide similar health benefits to silicone hydrogels without the drawbacks of incorporating hydrophobic silicone into the lens polymer.

NeoVista, Inc. has announced that the company’s revolutionary new surgical device is now available in the UK and offers fresh hope to 250,000 patients with wet age-related macular degeneration (AMD) –- a debilitating and aggressive eye condition that can lead to blindness within 3 months if left untreated. The VIDION® Anti NeoVascular (ANV®) Therapy System has recently received a CE mark certifying that it has met the EU’s Medical Device Directive.

Ophthalmic Imaging Systems has announced that it will launch two new products and improvements to the OIS EMR and OIS PM solutions. The OIS EyeScan is a revolutionary new portable imaging device that is capable of imaging both the anterior and posterior segment of the eye. By utilizing Digital Reporter with OIS’ market leading OIS Symphony Web Image Management System, large institutions will be able to document ophthalmic-specific data that their HIS cannot record.

The Gordon & Weiss Vision Institute is launching a new website to educate visitors on the many treatments available that can improve their vision and slow the progression of debilitating eye diseases. The new website is also designed to be a virtual portal into the practice itself, offering overviews of the facility, its doctors, and their philosophy of care. The new website features detailed descriptions of the procedures that the practice offers.

Ellex Medical Lasers Limited announced the launch of the latest version of the Eye Cubed(TM) diagnostic ultrasound system. Renowned for its unparalleled sensitivity and exceptional image resolution, the new generation Eye Cubed(TM) offers added functionality, including an intuitive software interface with user-friendly Windows-based operation; expanded measurement options via uniquely shaped calipers; improved export and import functions, as well as a host of other features.

SynergEyes Inc, the manufacturer of high Dk hybrid contact lens, has received the 22nd annual Most Innovative New Product (MIP) Award by CONNECT(R), a non-profit organization. SynergEyes was announced as a finalist for ClearKone(TM), its patent-pending advanced hybrid contact lens design for keratoconus patients. ClearKone(TM) is the first hybrid contact lens with FDA-clearance specifically designed for patients with emerging, moderate to advanced stages of keratoconus. This “hybrid” design incorporates the benefits of two types of contact lenses into one.

Revision Optics is close to entering an FDA study on a new lens design, the Presbylens, which is a small plastic lens that is implanted into the cornea to improve near vision. This could prove beneficial for millions of people suffering from aging of the eyes, or presbyopia. In a study conducted in Mexico, most patients were able to see 20/20 at distance and do near tasks including reading without the need for reading glasses. The FDA is yet to give approval for the start of this study.

BiCOM Inc sales have risen dramatically since the FDA has cleared its unique glaucoma IOP eye test through the Eyelid – Diaton Tonometer. The device is now available in every US state and more than 60 countries across the world through various medical device distributors. CEO of BiCOM, Roman Iospa predicts the sales of healthcare sector and medical diagnostic technology to increase.

LenSx Lasers has received 510(k) clearance from the FDA for its LenSx femtosecond laser. The approval marks the first time a femtosecond platform has been cleared by the FDA for performing anterior capsulotomy during cataract surgery. Preliminary clinical evaluation demonstrated the ability of the laser platform to produce capsulotomies with diameters that were significantly more uniform and reproducible than manually created capsulorrhexes.